Xenon Pharmaceuticals (XENE) announced the appointment of Tucker Kelly as Chief Financial Officer, CFO, and member of the Xenon senior executive team. Kelly most recently served as Executive Vice President, CFO and Treasurer at Deciphera Pharmaceuticals
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on XENE:
- Promising Outlook on Xenon Pharmaceuticals: Buy Rating Backed by Innovative Pain Treatment Developments
- Xenon Pharmaceuticals Issues Equity Inducement Grants to New Employees
- Xenon Pharmaceuticals to Host Investor Webinar on Non-Opioid Pain Treatments
- Xenon Pharmaceuticals assumed with an Overweight at Wells Fargo
- Xenon Pharmaceuticals’ Earnings Call Highlights Progress and Promise